Alliance Pharma PLC
07 May 2008
For immediate release 7 May 2008
RNS REACH
ALLIANCE PHARMA PLC
('Alliance Pharma' or 'the Company')
Chief Executive appointed to ABPI Board
Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, is
pleased to announce that John Dawson, the Company's Chief Executive, has been
appointed to the Board of Management of the Association of the British
Pharmaceutical Industry (ABPI), the UK trade association representing companies
engaged in research, development, manufacturing and marketing of prescription
medicines.
Mr Dawson was appointed to the ABPI Board in its recent elections and will serve
a one year term.
John Dawson, Alliance Pharma's Chief Executive, said: 'I am honoured to have
been elected to the Board of Management of the ABPI and look forward to serving
on it. I believe the ABPI performs an excellent role in promoting the interests
of all of the stakeholders in the UK's pharmaceutical industry and I look
forward to making a significant contribution to support its work, particularly
as important negotiations with Government are currently underway on the future
pricing systems for branded prescription medicines that are used by the NHS.'
For further information:
Alliance Pharma plc + 44 (0) 1249 466966
John Dawson, Chief Executive
Richard Wright, Finance Director
www.alliancepharma.co.uk
Buchanan Communications + 44 (0) 20 7466 5000
Mark Court / Rebecca Skye Dietrich
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.